Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

First ASCO Highlights Podcast: Dr. Pinder on Small Cell, Early Stage NSCLC, and Mesothelioma
Author
Howard (Jack) West, MD

Several weeks ago, we were fortunate enough to have Dr. Mary Pinder (alternately referred to as Pinder-Schenck) from the H. Lee Moffitt Cancer Center in Tampa join as the first of two speakers reviewing highlights in thoracic oncology from ASCO. She covered several key presentations in small cell lung cancer, early stage non-small cell lung cancer, and mesothelioma. Here's the audio and video versions of the podcast, along with the transcript and figures (a zip file to decompress, since it was too big in unzipped form to upload) for this program:

[powerpress]

pinder-asco-2011-highlights-sclc-early-stage-nsclc-and-meso-audio-podcast

pinder-asco-2011-highlights-sclc-early-stage-nsclc-and-meso-transcript

pinder-asco-2011-highlights-sclc-early-stage-nsclc-and-meso-figures

This program will be followed by Dr. Nasser Hanna's presentation of the highlights from advanced NSCLC at ASCO 2011, and then question and answer time as an additional podcast. The live webinar, as well as all of these podcasts, were developed in partnership with LUNGevity Foundation. We're very grateful for their support.

And for those of you reminded of how much you like Dr. Pinder, don't worry -- she's coming back for September.

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora